612 % des Ausgangsgewichtes erreicht und mit Semaglutid eine Gewichtsabnahme um circa 15 % (Grafik 2) (49, 50, 51, 52, 53)
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study
Whats happening is a combination of: Volume depletion in facial fat pads that support midface structure Muscle atrophy in the jawline, cheeks, and around the eyes Collagen breakdown , often accelerated by rapid body composition shifts Dehydration , which can impact skin tone and elasticity These facial changes can undermine the emotional benefits of weight lossand in some cases, make people feel older rather than healthier
When you reduce the number of free radicals your body has to fight, your existing glutathione can go further
, BPC 157